PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 250 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $83,000 | -8.8% | 1,561 | 0.0% | 0.02% | -8.7% |
| Q2 2022 | $91,000 | -48.3% | 1,561 | -32.7% | 0.02% | -42.5% |
| Q1 2022 | $176,000 | +633.3% | 2,318 | +489.8% | 0.04% | +566.7% |
| Q4 2021 | $24,000 | +9.1% | 393 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $22,000 | -59.3% | 393 | -56.0% | 0.01% | -57.1% |
| Q2 2021 | $54,000 | -81.2% | 893 | -78.2% | 0.01% | -83.1% |
| Q1 2021 | $287,000 | +825.8% | 4,093 | +694.8% | 0.08% | +730.0% |
| Q4 2020 | $31,000 | -24.4% | 515 | -23.7% | 0.01% | +25.0% |
| Q3 2020 | $41,000 | -47.4% | 675 | -54.6% | 0.01% | -72.4% |
| Q2 2020 | $78,000 | +212.0% | 1,487 | +102.3% | 0.03% | +141.7% |
| Q1 2020 | $25,000 | -24.2% | 735 | 0.0% | 0.01% | -7.7% |
| Q4 2019 | $33,000 | +17.9% | 735 | 0.0% | 0.01% | +30.0% |
| Q3 2019 | $28,000 | +3.7% | 735 | +20.3% | 0.01% | -9.1% |
| Q2 2019 | $27,000 | +17.4% | 611 | 0.0% | 0.01% | +10.0% |
| Q1 2019 | $23,000 | – | 611 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
| GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
| Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
| Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
| AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
| ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
| RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
| Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
| Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
| Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |